References
- Alverez F., Berg P. A., Bianchi F. B. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929–38
- Johnson P. J., McFarlane I. G., Williams R. Azathioprine for long‐term maintenance of remission in autoimmunehepatitis. N Engl J Med 1995; 333: 958–63
- Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I. P., et al. Activation of human aortic smooth‐muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998; 393: 790–3
- Okamoto H., Kamatani N. Successful treatment with fenofibrate, a peroxisome proliferator activated receptor alpha ligand, for a patient with rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1002–3
- Okamoto H., Iwamoto T., Kotake S., Momohara S., Yamanaka H., Kamatani N. Inhibition of NF‐kappaB signaling by fenofibrate, a peroxisome proliferator‐activated receptor‐alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 323–30
- Cornwell P. D., De Souza A. T., Ulrich R. G. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mutat Res 2004; 549: 131–45